h) What is the defective Immunosurveillance?
The cyclic AMP is not only a mere differentiation inducing substance but is basically the second messenger of hormone. Normally, a directive from the central nerve system is conveyed to cell through hormone and thereafter it is conveyed to DNA of the nucleus, however, in case of cancer patients, it maybe considered that decline of cyclic AMP in the blood creates a state wherein conveyance of the derective to cell nucleus is hindered resulting in the cancer cells "unsocial reactions".
For a long time, the defective immunosurveillance occurring in cancer patients, had been left unresearched as a mysterious phenomenon. However, our study has proved that it biochemically means "a decline of the concentration of cyclic AMP in the blood" (For details, please refer to Kobayashi T. Enhancement of immunosurveillance in cancer patients.Amer.J.of Acupuncture 15,25-33,1987)
To explain it simply, when an adopted lymphocyte therapy is given to cancer patients with 50 million lymphocytes, the immunity is improved with a 70-80% probability.
Whereas when the lymphocyte therapy is given to advanced cancer patients, the immunity is not much improved with a 33-39% probability. Since it was considered that defective immunosurveillance occurred in the advanced patients, beforehand a fasting therapy was given first and one or two days thereafter, adopted lymphocyte therapy with 50 million lymphocytes was given with a result that the immunity was improved with a 56-71% probability.
The improvement occurs because of the fact that the fasting treatment causes the cyclic AMP in the blood to increase. Through this experiment, the mysterious phenomenon called "defective immunosurveillance" in the field of immunity can be resolved by maintaining biochemically the cyclic AMP concentration in the blood within the normal range.
g) Application of differentiation inducing therapy.
The concentration of cyclic AMP in the blood of cancer patients is abated. Assuming that this is what the defective immunosurveillance means in essence biochemically, then measures to restore the concentration of cyclic AMP in the blood back to stay within the normal range by having the patient undergo a fasting therapy or semi-fasting treatment, should be taken.
As a medical treatment, in this regard, a small quantity of dibutryI cyclic AMP is injected intravenously for a period of 6〜24 hours continuously.
At the same time, if it is made possible to keep the cyclic AMP concentration in the blood at a comparatively high level for a long time, by injecting intravenously aminophylline for a period of 6〜24 hours continuously, which blocks the action of cyclic phosphodiesterase(cPDE) which decomposes cyclic AMP, then the defective immunosurveillance will be improved thus making the defferentiation inducing therapy possible.
The photos below show the differentiation of brain tumor cell (left photo) into normal nerve cell (right photo) as a result of its cultivation adding cyclic AMP. |